A novel one-time intravenous gene therapy infusion could potentially cure patients with severe hemophilia B. Four patients from the small trial have had such success that they have discontinued traditional treatment.

A common drug that stops bleeding in patients with severe hemophilia, a rare bleeding disorder in which the blood doesn't clot normally, may also be able to prevent such bleeds altogether.